Loading
MY-RADS is a standard way to perform, read and report whole-body MRI in myeloma, both at diagnosis and when judging response to treatment.
An international panel of radiologists, physicists and haematologists, following guidance from the International Myeloma Working Group and NICE, wrote the Myeloma Response Assessment and Diagnosis System (Messiou and colleagues, Radiology 2019). It proposes a core clinical whole-body MRI protocol and an extended one for advanced assessment, to reduce variation in how the scans are acquired, interpreted and reported and to allow response assessment.
Showing the technology this term belongs to: Whole-body MRI.
Shares IMWG response criteria for myeloma (2016, with MRD), Multiple myeloma.
Shares IMWG response criteria for myeloma (2016, with MRD), Multiple myeloma.
Shares ONCO-RADS (whole-body MRI screening in people at high risk), Whole-body MRI.
Shares IMWG response criteria for myeloma (2016, with MRD), Multiple myeloma.
Shares Whole-body MRI, Multiple myeloma.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/